Insulet Corp (PODD)
187.27
+1.89
(+1.02%)
USD |
NASDAQ |
May 17, 16:00
187.38
+0.11
(+0.06%)
After-Hours: 20:00
Insulet Net Income (Annual): 206.30M for Dec. 31, 2023
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 206.30M |
| December 31, 2022 | 4.60M |
| December 31, 2021 | 16.80M |
| December 31, 2020 | 6.80M |
| December 31, 2019 | 11.60M |
| December 31, 2018 | 3.30M |
| December 31, 2017 | -26.80M |
| December 31, 2016 | -28.88M |
| December 31, 2015 | -73.52M |
| December 31, 2014 | -51.50M |
| December 31, 2013 | -44.97M |
| Date | Value |
|---|---|
| December 31, 2012 | -51.87M |
| December 31, 2011 | -45.83M |
| December 31, 2010 | -61.16M |
| December 31, 2009 | -72.34M |
| December 31, 2008 | -94.77M |
| December 31, 2007 | -53.54M |
| December 31, 2006 | -35.95M |
| December 31, 2005 | -21.64M |
| December 31, 2004 | -13.82M |
| December 31, 2003 | -11.94M |
| December 31, 2002 | -12.58M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Annual) Range, Past 5 Years
4.60M
Minimum
2022
206.30M
Maximum
2023
49.22M
Average
11.60M
Median
2019
Net Income (Annual) Benchmarks
| Stryker Corp | 3.165B |
| Tandem Diabetes Care Inc | -222.61M |
| Abbott Laboratories | 5.723B |
| ResMed Inc | 897.56M |
| Integra Lifesciences Holdings Corp | 67.74M |